Skip to content

The prevalence and risk factors of hyperuricemia in diabetic patients in Chenghua district of Chengdu

To investigate the prevalence and risk factors of hyperuricemia in diabetic patients in Chenghua district of Chengdu

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042742
Enrollment
Unknown
Registered
2021-01-27
Start date
2021-02-23
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Interventions

case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) The subjects are permanent residents of Chenghua community, ensuring follow-up without loss; (2) Patients with the ages from 18 to 80; (3) Men and women are not limited; (4) Patients diagnosed with diabetes; (5) The patients and their families agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) People with mental retardation, mental disorders and other special groups who cannot fully understand the purpose of the study; (2) Patients with acute cardiovascular and cerebrovascular events, unstable conditions or requiring hospitalization within 3 months before the study; (3) People with cardiovascular and cerebrovascular events or hemiplegia occurred more than 3 months before entering the study, which was not convenient for investigation; (4) Patients diagnosed with malignant tumors within 3 months prior to study entry and requiring hospitalization or special treatment; (5) The researcher considered that the patient could not be included.

Design outcomes

Primary

MeasureTime frame
Liver Function;Renal Function;Glycosylated Hemoglobin;Serum Lipid;Urine Routine;HLA-5801;Uric acid excretion rate;Ankle brachial index;Glycated Albumin;

Countries

China

Contacts

Public ContactXingwu Ran

Department of Endocrinology and Metabolism, West China Hospital of Sichuan University

ranxingwu@163.com+86 18980601305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026